UniProt ID | DPYL3_HUMAN | |
---|---|---|
UniProt AC | Q14195 | |
Protein Name | Dihydropyrimidinase-related protein 3 | |
Gene Name | DPYSL3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 570 | |
Subcellular Localization | Cytoplasm. Cell projection, growth cone. Colocalizes with synaptic vesicle protein 2 in the central region of the growth cone.. | |
Protein Description | Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration (By similarity).. | |
Protein Sequence | MSYQGKKNIPRITSDRLLIKGGRIVNDDQSFYADIYMEDGLIKQIGDNLIVPGGVKTIEANGKMVIPGGIDVHTHFQMPYKGMTTVDDFFQGTKAALAGGTTMIIDHVVPEPESSLTEAYEKWREWADGKSCCDYALHVDITHWNDSVKQEVQNLIKDKGVNSFMVYMAYKDLYQVSNTELYEIFTCLGELGAIAQVHAENGDIIAQEQTRMLEMGITGPEGHVLSRPEELEAEAVFRAITIASQTNCPLYVTKVMSKSAADLISQARKKGNVVFGEPITASLGIDGTHYWSKNWAKAAAFVTSPPLSPDPTTPDYINSLLASGDLQLSGSAHCTFSTAQKAIGKDNFTAIPEGTNGVEERMSVIWDKAVATGKMDENQFVAVTSTNAAKIFNLYPRKGRISVGSDSDLVIWDPDAVKIVSAKNHQSAAEYNIFEGMELRGAPLVVICQGKIMLEDGNLHVTQGAGRFIPCSPFSDYVYKRIKARRKMADLHAVPRGMYDGPVFDLTTTPKGGTPAGSARGSPTRPNPPVRNLHQSGFSLSGTQVDEGVRSASKRIVAPPGGRSNITSLS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSYQGKKNI ------CCCCCCCCC | 26.60 | 21406692 | |
3 | Phosphorylation | -----MSYQGKKNIP -----CCCCCCCCCC | 21.71 | 18083107 | |
10 (in isoform 2) | Phosphorylation | - | 30.89 | 26657352 | |
11 (in isoform 2) | Phosphorylation | - | 40.81 | 30266825 | |
13 | Phosphorylation | KKNIPRITSDRLLIK CCCCCCCCCCCEEEE | 26.34 | 28450419 | |
14 | Phosphorylation | KNIPRITSDRLLIKG CCCCCCCCCCEEEEC | 20.54 | 28450419 | |
19 (in isoform 2) | Phosphorylation | - | 4.63 | 27642862 | |
25 (in isoform 2) | Phosphorylation | - | 6.56 | 27251275 | |
26 (in isoform 2) | Phosphorylation | - | 44.78 | 27251275 | |
30 | Phosphorylation | RIVNDDQSFYADIYM EECCCCCCCEEEEEE | 27.50 | 24076635 | |
32 | Phosphorylation | VNDDQSFYADIYMED CCCCCCCEEEEEECC | 14.49 | 19652227 | |
37 | Sulfoxidation | SFYADIYMEDGLIKQ CCEEEEEECCCCEEE | 3.75 | 30846556 | |
48 (in isoform 2) | Acetylation | - | 26.84 | - | |
49 (in isoform 2) | Phosphorylation | - | 5.06 | 27732954 | |
56 (in isoform 2) | Phosphorylation | - | 47.24 | 22199227 | |
60 (in isoform 2) | Methylation | - | 26.65 | - | |
67 (in isoform 2) | Phosphorylation | - | 24.44 | 30177828 | |
71 (in isoform 2) | Phosphorylation | - | 29.44 | 30177828 | |
73 (in isoform 2) | Methylation | - | 15.18 | - | |
75 (in isoform 2) | Phosphorylation | - | 8.96 | 25850435 | |
77 (in isoform 2) | Phosphorylation | - | 25.08 | 25850435 | |
83 | Sulfoxidation | FQMPYKGMTTVDDFF CCCCCCCCCCHHHHH | 2.19 | 30846556 | |
85 (in isoform 2) | Phosphorylation | - | 17.03 | 30266825 | |
95 (in isoform 2) | Phosphorylation | - | 13.93 | 25850435 | |
101 | Phosphorylation | KAALAGGTTMIIDHV HHHHCCCCEEEEECC | 16.57 | - | |
102 | Phosphorylation | AALAGGTTMIIDHVV HHHCCCCEEEEECCC | 15.06 | 22798277 | |
102 (in isoform 2) | Phosphorylation | - | 15.06 | 30266825 | |
103 | Sulfoxidation | ALAGGTTMIIDHVVP HHCCCCEEEEECCCC | 2.25 | 30846556 | |
112 (in isoform 2) | Phosphorylation | - | 40.47 | 24719451 | |
114 (in isoform 2) | Phosphorylation | - | 41.17 | 21406692 | |
146 (in isoform 2) | Phosphorylation | - | 50.01 | 27251275 | |
251 | Phosphorylation | SQTNCPLYVTKVMSK HHCCCCEEEEECCCC | 7.39 | 25884760 | |
253 | Phosphorylation | TNCPLYVTKVMSKSA CCCCEEEEECCCCCH | 12.36 | - | |
257 | Phosphorylation | LYVTKVMSKSAADLI EEEEECCCCCHHHHH | 26.84 | - | |
258 | Succinylation | YVTKVMSKSAADLIS EEEECCCCCHHHHHH | 26.47 | - | |
259 | Phosphorylation | VTKVMSKSAADLISQ EEECCCCCHHHHHHH | 22.76 | 22617229 | |
265 | Phosphorylation | KSAADLISQARKKGN CCHHHHHHHHHHHCC | 25.69 | 23403867 | |
280 | Phosphorylation | VVFGEPITASLGIDG EEECCCEEEECCCCC | 22.40 | 28348404 | |
282 | Phosphorylation | FGEPITASLGIDGTH ECCCEEEECCCCCCE | 20.62 | 27251275 | |
288 | Phosphorylation | ASLGIDGTHYWSKNW EECCCCCCEECCCCH | 14.19 | 28348404 | |
292 | Phosphorylation | IDGTHYWSKNWAKAA CCCCEECCCCHHHHE | 14.67 | 28348404 | |
293 | Ubiquitination | DGTHYWSKNWAKAAA CCCEECCCCHHHHEE | 42.22 | - | |
303 | Phosphorylation | AKAAAFVTSPPLSPD HHHEEEECCCCCCCC | 29.12 | 20068231 | |
304 | Phosphorylation | KAAAFVTSPPLSPDP HHEEEECCCCCCCCC | 21.15 | 20068231 | |
308 | Phosphorylation | FVTSPPLSPDPTTPD EECCCCCCCCCCCHH | 32.79 | 21406692 | |
316 | Nitrated tyrosine | PDPTTPDYINSLLAS CCCCCHHHHHHHHHH | 11.82 | - | |
345 | Ubiquitination | TAQKAIGKDNFTAIP HHHHHHCCCCCEECC | 43.30 | - | |
362 | Sulfoxidation | TNGVEERMSVIWDKA CCCHHHHHHHHHHHH | 4.19 | 30846556 | |
363 | Phosphorylation | NGVEERMSVIWDKAV CCHHHHHHHHHHHHH | 19.37 | 25332170 | |
373 (in isoform 2) | Phosphorylation | - | 17.35 | 24719451 | |
374 | Ubiquitination | DKAVATGKMDENQFV HHHHHCCCCCCCCEE | 38.53 | - | |
375 | Sulfoxidation | KAVATGKMDENQFVA HHHHCCCCCCCCEEE | 9.16 | 30846556 | |
385 | Phosphorylation | NQFVAVTSTNAAKIF CCEEEEEECCHHHHC | 17.05 | 23911959 | |
396 (in isoform 2) | Phosphorylation | - | 34.37 | 27251275 | |
398 | Acetylation | IFNLYPRKGRISVGS HCCCCCCCCCEECCC | 48.30 | 19666971 | |
402 | Phosphorylation | YPRKGRISVGSDSDL CCCCCCEECCCCCCE | 21.04 | 26657352 | |
405 | Phosphorylation | KGRISVGSDSDLVIW CCCEECCCCCCEEEE | 31.61 | 28857561 | |
407 | Phosphorylation | RISVGSDSDLVIWDP CEECCCCCCEEEECC | 34.24 | 28857561 | |
423 | Ubiquitination | AVKIVSAKNHQSAAE CEEEEECCCCCCHHH | 47.67 | - | |
431 | Phosphorylation | NHQSAAEYNIFEGME CCCCHHHCCCCCCCC | 14.61 | 22817900 | |
437 | Sulfoxidation | EYNIFEGMELRGAPL HCCCCCCCCCCCCCE | 3.27 | 30846556 | |
448 | S-palmitoylation | GAPLVVICQGKIMLE CCCEEEEECCEEEEE | 2.70 | 29575903 | |
462 | Phosphorylation | EDGNLHVTQGAGRFI ECCCEEEEECCCCCC | 15.55 | 21406692 | |
472 | Phosphorylation | AGRFIPCSPFSDYVY CCCCCCCCCCHHHHH | 24.51 | 26657352 | |
475 | Phosphorylation | FIPCSPFSDYVYKRI CCCCCCCHHHHHHHH | 31.26 | 23403867 | |
477 | Phosphorylation | PCSPFSDYVYKRIKA CCCCCHHHHHHHHHH | 12.41 | 23403867 | |
479 | Phosphorylation | SPFSDYVYKRIKARR CCCHHHHHHHHHHHH | 6.58 | 21406692 | |
488 | Sulfoxidation | RIKARRKMADLHAVP HHHHHHHHHCCCCCC | 3.13 | 30846556 | |
498 | Sulfoxidation | LHAVPRGMYDGPVFD CCCCCCCCCCCCEEE | 2.66 | 30846556 | |
499 | Phosphorylation | HAVPRGMYDGPVFDL CCCCCCCCCCCEEEE | 22.14 | 23403867 | |
507 | Phosphorylation | DGPVFDLTTTPKGGT CCCEEEEECCCCCCC | 30.39 | 29255136 | |
508 | Phosphorylation | GPVFDLTTTPKGGTP CCEEEEECCCCCCCC | 48.69 | 29255136 | |
509 | Phosphorylation | PVFDLTTTPKGGTPA CEEEEECCCCCCCCC | 20.12 | 19664994 | |
511 | Ubiquitination | FDLTTTPKGGTPAGS EEEECCCCCCCCCCC | 68.81 | - | |
514 | Phosphorylation | TTTPKGGTPAGSARG ECCCCCCCCCCCCCC | 20.73 | 23401153 | |
518 | Phosphorylation | KGGTPAGSARGSPTR CCCCCCCCCCCCCCC | 19.52 | 23401153 | |
519 (in isoform 2) | Phosphorylation | - | 20.95 | 27251275 | |
521 (in isoform 2) | Phosphorylation | - | 37.38 | 24719451 | |
522 | Phosphorylation | PAGSARGSPTRPNPP CCCCCCCCCCCCCCC | 19.97 | 29255136 | |
524 | Phosphorylation | GSARGSPTRPNPPVR CCCCCCCCCCCCCCC | 61.53 | 21955146 | |
536 | Phosphorylation | PVRNLHQSGFSLSGT CCCCCCCCCCCCCCC | 30.93 | 26055452 | |
539 | Phosphorylation | NLHQSGFSLSGTQVD CCCCCCCCCCCCCCC | 25.75 | 26846344 | |
541 | Phosphorylation | HQSGFSLSGTQVDEG CCCCCCCCCCCCCHH | 38.30 | 26846344 | |
543 | Phosphorylation | SGFSLSGTQVDEGVR CCCCCCCCCCCHHHH | 23.26 | 23403867 | |
551 | Phosphorylation | QVDEGVRSASKRIVA CCCHHHHHCCCEEEC | 34.19 | 21712546 | |
553 | Phosphorylation | DEGVRSASKRIVAPP CHHHHHCCCEEECCC | 24.58 | 29496963 | |
563 | Asymmetric dimethylarginine | IVAPPGGRSNITSLS EECCCCCCCCCCCCC | 32.23 | - | |
564 | Phosphorylation | VAPPGGRSNITSLS- ECCCCCCCCCCCCC- | 35.54 | 24670416 | |
567 | Phosphorylation | PGGRSNITSLS---- CCCCCCCCCCC---- | 28.06 | 29514088 | |
568 | Phosphorylation | GGRSNITSLS----- CCCCCCCCCC----- | 23.87 | 29514088 | |
570 | Phosphorylation | RSNITSLS------- CCCCCCCC------- | 37.63 | 29514088 | |
586 (in isoform 2) | Phosphorylation | - | 24719451 | ||
621 (in isoform 2) | Phosphorylation | - | 24719451 | ||
622 (in isoform 2) | Phosphorylation | - | 27251275 | ||
623 (in isoform 2) | Phosphorylation | - | 27251275 | ||
628 (in isoform 2) | Phosphorylation | - | 24719451 | ||
632 (in isoform 2) | Phosphorylation | - | 24719451 | ||
636 (in isoform 2) | Phosphorylation | - | 24719451 | ||
650 (in isoform 2) | Phosphorylation | - | 24719451 | ||
653 (in isoform 2) | Phosphorylation | - | 24719451 | ||
655 (in isoform 2) | Phosphorylation | - | 24719451 | ||
665 (in isoform 2) | Phosphorylation | - | 24719451 | ||
681 (in isoform 2) | Phosphorylation | - | 24719451 | ||
684 (in isoform 2) | Phosphorylation | - | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
509 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
509 | T | Phosphorylation | Kinase | GSK-FAMILY | - | GPS |
509 | T | Phosphorylation | Kinase | GSK3 | - | Uniprot |
514 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
514 | T | Phosphorylation | Kinase | GSK-FAMILY | - | GPS |
514 | T | Phosphorylation | Kinase | GSK3 | - | Uniprot |
518 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
518 | S | Phosphorylation | Kinase | GSK-FAMILY | - | GPS |
518 | S | Phosphorylation | Kinase | GSK3 | - | Uniprot |
522 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
522 | S | Phosphorylation | Kinase | DYRK2 | Q92630 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DPYL3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBB5_BOVIN | TUBB | physical | 12134159 | |
CUL2_HUMAN | CUL2 | physical | 22863883 | |
PLAK_HUMAN | JUP | physical | 22863883 | |
F10A1_HUMAN | ST13 | physical | 22863883 | |
DPYL1_HUMAN | CRMP1 | physical | 28514442 | |
DPYL2_HUMAN | DPYSL2 | physical | 28514442 | |
DPYL4_HUMAN | DPYSL4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Distinct priming kinases contribute to differential regulation ofcollapsin response mediator proteins by glycogen synthase kinase-3 invivo."; Cole A.R., Causeret F., Yadirgi G., Hastie C.J., McLauchlan H.,McManus E.J., Hernandez F., Eickholt B.J., Nikolic M., Sutherland C.; J. Biol. Chem. 281:16591-16598(2006). Cited for: PHOSPHORYLATION AT SER-522 BY DYRK2, AND PHOSPHORYLATION AT THR-509;THR-514 AND SER-518 BY GSK3. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522 AND SER-551, ANDMASS SPECTROMETRY. |